DeepMed Research

Winston, Marvin

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Civamide Nasal Solution for the Treatment of Dry Eye

Phase 2

Completed

Conditions: Dry Eye

Interventions: Drug: Civamide Nasal Spray

First Posted Date: 2014-04-16

Last Posted Date: 2017-02-10

Lead Sponsor: Winston Laboratories

Target Recruit Count: 31

Registration Number: NCT02116244

Locations: 🇺🇸
Wohl Eye Center, Bloomingdale, Illinois, United States
🇺🇸
NorthShore University HealthSystem, Glenview, Illinois, United States
🇺🇸
Chicago Cornea Consultants, Ltd., Hoffman Estates, Illinois, United States

Civamide Nasal Solution for Postherpetic Neuralgia of the Trigeminal Nerve

Phase 2

Terminated

Conditions: Postherpetic Neuralgia

Interventions: Drug: Civamide Nasal Spray
Drug: Placebo

First Posted Date: 2013-06-25

Last Posted Date: 2017-03-01

Lead Sponsor: Winston Laboratories

Target Recruit Count: 11

Registration Number: NCT01886313

Locations: 🇺🇸
Michigan Head Pain and Neurological Institute, Ann Arbor, Michigan, United States
🇺🇸
California Medical Clinic for Headache, Santa Monica, California, United States
🇺🇸
Meridien Research, Tampa, Florida, United States

and more 2 locations

Civamide Nasal Solution for Cluster Headache

Phase 3

Not yet recruiting

Conditions: Episodic Cluster Headache

Interventions: Drug: Civamide nasal solution 0.01%

First Posted Date: 2011-04-25

Last Posted Date: 2021-04-23

Lead Sponsor: Winston Laboratories

Target Recruit Count: 180

Registration Number: NCT01341548

Evaluating the Safety and Efficacy Civamide in Osteoarthritis (OA) of the Knee(s)

Phase 3

Completed

Conditions: Osteoarthritis of the Knee

Interventions: Drug: Civamide (Zucapsaicin)

First Posted Date: 2009-10-15

Last Posted Date: 2011-06-10

Lead Sponsor: Winston Laboratories

Target Recruit Count: 695

Registration Number: NCT00995306

Evaluation of Civamide Patch in Treatment of Postherpetic Neuralgia and Post-Incisional Neuralgia

Phase 2

Completed

Conditions: Postherpetic Neuralgia

Interventions: Drug: Civamide Patch

First Posted Date: 2009-02-18

Last Posted Date: 2017-02-13

Lead Sponsor: Winston Laboratories

Target Recruit Count: 22

Registration Number: NCT00845923

Locations: 🇺🇸
Neurology Clinical Research, Inc., Sunrise, Florida, United States
🇺🇸
Michigan Head-Pain and Neurological Institute, Ann Arbor, Michigan, United States
🇨🇦
U.T. Pain Specialist, Etobicoke, Ontario, Canada

and more 1 locations

Oral Civamide Safety, Tolerability First in Human Study

Phase 1

Terminated

Conditions: Healthy

Interventions: Drug: Civamide

First Posted Date: 2008-12-04

Last Posted Date: 2011-06-10

Lead Sponsor: Winston Laboratories

Target Recruit Count: 12

Registration Number: NCT00802217

Locations: 🇺🇸
Parexel International, Inc., Baltimore, Maryland, United States

Civamide Patch Safety, Tolerability and PK Study

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: Zucapsaicin
Drug: Placebo patch

First Posted Date: 2008-09-25

Last Posted Date: 2011-06-10

Lead Sponsor: Winston Laboratories

Target Recruit Count: 39

Registration Number: NCT00758433

Locations: 🇺🇸
International Research Services, Inc., Port Chester, New York, United States

Civamide in OA of the Knee(s)

Phase 3

Completed

Conditions: Osteoarthritis, Knee

First Posted Date: 2004-02-18

Last Posted Date: 2011-06-08

Lead Sponsor: Winston Laboratories

Target Recruit Count: 351

Registration Number: NCT00077935

Locations: 🇺🇸
NC Arthritis and Allergy Care Center, Raleigh, North Carolina, United States
🇺🇸
Chesapeake Medical Research, LLC, Baltimore, Maryland, United States
🇺🇸
University Hospitals of Cleveland, Beachwood, Ohio, United States

and more 26 locations

Intranasal Civamide for Episodic Cluster Headache

Phase 3

Completed

Conditions: Episodic Cluster Headache

Interventions: Drug: Civamide (Zucapsaicin)
Drug: Sodium Chloride

First Posted Date: 2003-09-16

Last Posted Date: 2011-06-10

Lead Sponsor: Winston Laboratories

Target Recruit Count: 2

Registration Number: NCT00069082

Locations: 🇺🇸
California Medical Clinic for Headache, Santa Monica, California, United States
🇺🇸
Diamond Headache Clinic, Chicago, Illinois, United States
🇺🇸
Colorado Neurology and Headache Clinic, Denver, Colorado, United States

and more 3 locations

A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache

Phase 3

Completed

Conditions: Episodic Cluster Headache

First Posted Date: 2002-04-12

Last Posted Date: 2011-06-10

Lead Sponsor: Winston Laboratories

Target Recruit Count: 60

Registration Number: NCT00033839

Locations: 🇺🇸
The Headache Wellness Center, Greensboro, North Carolina, United States
🇺🇸
Diamond Headache Clinic, Chicago, Illinois, United States
🇺🇸
Neurological Associates of Tucson, Tucson, Arizona, United States

and more 23 locations

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy